Ana Carina FerreiraNephrology Department – Hospital Curry Cabral, Centro Hospitalar e Universitário de Lisboa Central, Lisbon, Portugal NOVA Medical School – Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Lisbon, Portugal
Aníbal FerreiraNephrology Department – Hospital Curry Cabral, Centro Hospitalar e Universitário de Lisboa Central, Lisbon, Portugal NOVA Medical School – Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Lisbon, Portugal
Cannata-AndíaJB, Martín-CarroB, Martín-VírgalaJ, Rodríguez-CarrioJ, Bande-FernándezJJ, Alonso-MontesC, et al.: Chronic kidney disease-mineral and bone disorders: Pathogenesis and management. Calcif Tissue Int108: 410–422, 2021PubMed
Cannata-AndíaJB, Martín-CarroB, Martín-VírgalaJ, Rodríguez-CarrioJ, Bande-FernándezJJ, Alonso-MontesC, et al.: Chronic kidney disease-mineral and bone disorders: Pathogenesis and management. Calcif Tissue Int 108: 410–422, 2021PubMed)| false
KettelerM, BlockGA, EvenepoelP, FukagawaM, HerzogCA, McCannL, et al.: Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: What’s changed and why it matters. Kidney Int92: 26–36, 2017PubMed
KettelerM, BlockGA, EvenepoelP, FukagawaM, HerzogCA, McCannL, et al.: Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: What’s changed and why it matters. Kidney Int 92: 26–36, 2017PubMed)| false
MoeS, DrüekeT, CunninghamJ, GoodmanW, MartinK, OlgaardK, et al.; Kidney Disease: Improving Global Outcomes (KDIGO): Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int69: 1945–1953, 2006PubMed
MoeS, DrüekeT, CunninghamJ, GoodmanW, MartinK, OlgaardK, et al.; Kidney Disease: Improving Global Outcomes (KDIGO): Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int 69: 1945–1953, 2006PubMed)| false
EvenepoelP, D’HaeseP, BacchettaJ, Cannata-AndiaJ, FerreiraA, HaarhausM, et al.; ERA-EDTA Working Group on CKD-MBD: Bone biopsy practice patterns across Europe: The European renal osteodystrophy initiative-a position paper. Nephrol Dial Transplant32: 1608–1613, 2017PubMed
EvenepoelP, D’HaeseP, BacchettaJ, Cannata-AndiaJ, FerreiraA, HaarhausM, et al.; ERA-EDTA Working Group on CKD-MBD: Bone biopsy practice patterns across Europe: The European renal osteodystrophy initiative-a position paper. Nephrol Dial Transplant 32: 1608–1613, 2017PubMed)| false
FerreiraAC, Cohen-SolalM, D’HaesePC, FerreiraA; European Renal Osteodystrophy (EUROD), an initiative of the CKD-MBD working group of the ERA-EDTA: The role of bone biopsy in the management of CKD-MBD. Calcif Tissue Int108: 528–538, 2021PubMed
FerreiraAC, Cohen-SolalM, D’HaesePC, FerreiraA; European Renal Osteodystrophy (EUROD), an initiative of the CKD-MBD working group of the ERA-EDTA: The role of bone biopsy in the management of CKD-MBD. Calcif Tissue Int 108: 528–538, 2021PubMed)| false
DelaisseJM, AndersenTL, KristensenHB, JensenPR, AndreasenCM, SøeK: Re-thinking the bone remodeling cycle mechanism and the origin of bone loss. Bone141: 115628, 2020PubMed
DelaisseJM, AndersenTL, KristensenHB, JensenPR, AndreasenCM, SøeK: Re-thinking the bone remodeling cycle mechanism and the origin of bone loss. Bone 141: 115628, 2020PubMed)| false
KakaniE, ElyamnyM, AyachT, El-HusseiniA: Pathogenesis and management of vascular calcification in CKD and dialysis patients. Semin Dial32: 553–561, 2019PubMed
KakaniE, ElyamnyM, AyachT, El-HusseiniA: Pathogenesis and management of vascular calcification in CKD and dialysis patients. Semin Dial 32: 553–561, 2019PubMed)| false
BlockGA, KlassenPS, LazarusJM, OfsthunN, LowrieEG, ChertowGM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol15: 2208–2218, 2004PubMed
BlockGA, KlassenPS, LazarusJM, OfsthunN, LowrieEG, ChertowGM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208–2218, 2004PubMed)| false
BlockGA, ChertowGM, CooperK, XingS, FouquerayB, HalperinM, et al.: Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trial. Hemodial Int25: 78–85, 2021PubMed
BlockGA, ChertowGM, CooperK, XingS, FouquerayB, HalperinM, et al.: Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trial. Hemodial Int 25: 78–85, 2021PubMed)| false
PimentelA, Ureña-TorresP, ZillikensMC, BoverJ, Cohen-SolalM: Fractures in patients with CKD-diagnosis, treatment, and prevention: A review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation. Kidney Int92: 1343–1355, 2017PubMed
PimentelA, Ureña-TorresP, ZillikensMC, BoverJ, Cohen-SolalM: Fractures in patients with CKD-diagnosis, treatment, and prevention: A review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation. Kidney Int 92: 1343–1355, 2017PubMed)| false
PimentelA, Ureña-TorresP, BoverJ, Luis Fernandez-MartínJ, Cohen-SolalM: Bone fragility fractures in CKD patients. Calcif Tissue Int108: 539–550, 2021PubMed
PimentelA, Ureña-TorresP, BoverJ, Luis Fernandez-MartínJ, Cohen-SolalM: Bone fragility fractures in CKD patients. Calcif Tissue Int 108: 539–550, 2021PubMed)| false
TentoriF, McCulloughK, KilpatrickRD, BradburyBD, RobinsonBM, KerrPG, et al.: High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int85: 166–173, 2014PubMed
TentoriF, McCulloughK, KilpatrickRD, BradburyBD, RobinsonBM, KerrPG, et al.: High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85: 166–173, 2014PubMed)| false
HaarhausM, EvenepoelP; European Renal Osteodystrophy (EUROD) workgroup; Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA): Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment. Kidney Int100: 546–558, 2021PubMed
HaarhausM, EvenepoelP; European Renal Osteodystrophy (EUROD) workgroup; Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA): Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment. Kidney Int 100: 546–558, 2021PubMed)| false
HernandesFR, CanzianiME, BarretoFC, SantosRO, MoreiraVM, RochitteCE, et al.: The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: A 12-month follow-up study. PLoS One12: e0174811, 2017PubMed
HernandesFR, CanzianiME, BarretoFC, SantosRO, MoreiraVM, RochitteCE, et al.: The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: A 12-month follow-up study. PLoS One 12: e0174811, 2017PubMed)| false
NetoR, PereiraL, MagalhãesJ, Quelhas-SantosJ, FrazãoJ: Low bone turnover is associated with plain X-ray vascular calcification in predialysis patients. PLoS One16: e0258284, 2021PubMed
NetoR, PereiraL, MagalhãesJ, Quelhas-SantosJ, FrazãoJ: Low bone turnover is associated with plain X-ray vascular calcification in predialysis patients. PLoS One 16: e0258284, 2021PubMed)| false
FerreiraAC, CotovioP, AiresI, MendesM, NavarroD, SilvaC, et al.: The role of bone volume, FGF23 and sclerostin in calcifications and mortality; a cohort study in CKD stage 5 patients. Calcif Tissue Int110: 215–224, 2022PubMed
FerreiraAC, CotovioP, AiresI, MendesM, NavarroD, SilvaC, et al.: The role of bone volume, FGF23 and sclerostin in calcifications and mortality; a cohort study in CKD stage 5 patients. Calcif Tissue Int 110: 215–224, 2022PubMed)| false
FerreiraAC, MendesM, SilvaC, CotovioP, AiresI, NavarroD, et al.: Improvement of mineral and bone disorders after renal transplantation. Transplantation106: e251–e261, 2022PubMed
FerreiraAC, MendesM, SilvaC, CotovioP, AiresI, NavarroD, et al.: Improvement of mineral and bone disorders after renal transplantation. Transplantation 106: e251–e261, 2022PubMed)| false
CarbonaraCEM, ReisLMD, QuadrosKRDS, RozaNAV, SanoR, CarvalhoAB, et al.: Renal osteodystrophy and clinical outcomes: Data from the Brazilian Registry of Bone Biopsies - REBRABO. J Bras Nefrol42: 138–146, 2020PubMed
CarbonaraCEM, ReisLMD, QuadrosKRDS, RozaNAV, SanoR, CarvalhoAB, et al.: Renal osteodystrophy and clinical outcomes: Data from the Brazilian Registry of Bone Biopsies - REBRABO. J Bras Nefrol 42: 138–146, 2020PubMed)| false
Novel-CatinE, PelletierS, FouqueD, RouxJP, ChapurlatR, D’HaeseP, et al.: Quantitative histomorphometric analysis of halved iliac crest bone biopsies yield comparable ROD diagnosis as full 7.5mm wide samples. Bone138: 115460, 2020PubMed
Novel-CatinE, PelletierS, FouqueD, RouxJP, ChapurlatR, D’HaeseP, et al.: Quantitative histomorphometric analysis of halved iliac crest bone biopsies yield comparable ROD diagnosis as full 7.5mm wide samples. Bone 138: 115460, 2020PubMed)| false
Steller Wagner MartinsC, JorgettiV, MoysésRMA: Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease. Curr Opin Nephrol Hypertens27: 243–250, 2018PubMed
Steller Wagner MartinsC, JorgettiV, MoysésRMA: Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 27: 243–250, 2018PubMed)| false
JørgensenHS, BehetsG, ViaeneL, BammensB, ClaesK, MeijersB, et al.: Static histomorphometry allows for a diagnosis of bone turnover in renal osteodystrophy in the absence of tetracycline labels. Bone152: 116066, 2021PubMed
JørgensenHS, BehetsG, ViaeneL, BammensB, ClaesK, MeijersB, et al.: Static histomorphometry allows for a diagnosis of bone turnover in renal osteodystrophy in the absence of tetracycline labels. Bone 152: 116066, 2021PubMed)| false
SalamS, GallagherO, HughesD, KhwajaA, EastellR: The role of static bone histomorphometry in diagnosing renal osteodystrophy. Bone142: 115689, 2021PubMed
SalamS, GallagherO, HughesD, KhwajaA, EastellR: The role of static bone histomorphometry in diagnosing renal osteodystrophy. Bone 142: 115689, 2021PubMed)| false
JørgensenHS, FerreiraAC, D’HaeseP, HaarhausM, VervloetM, Lafage-ProustMH, et al.; European Renal Osteodystrophy (EUROD) workgroup; Chronic Kidney Disease - Mineral and Bone Disorder Working Group (CKD-MBD WG): Bone histomorphometry for the diagnosis of renal osteodystrophy: A call for harmonization of reference ranges. Kidney Int102: 431–434, 2022PubMed
JørgensenHS, FerreiraAC, D’HaeseP, HaarhausM, VervloetM, Lafage-ProustMH, et al.; European Renal Osteodystrophy (EUROD) workgroup; Chronic Kidney Disease - Mineral and Bone Disorder Working Group (CKD-MBD WG): Bone histomorphometry for the diagnosis of renal osteodystrophy: A call for harmonization of reference ranges. Kidney Int 102: 431–434, 2022PubMed)| false
El-HusseiniA, NagyE, BarretoFC: Is bone histomorphometry required for assessment of renal osteodystrophy in clinical practice?Kidney Int102: 670, 2022PubMed
El-HusseiniA, NagyE, BarretoFC: Is bone histomorphometry required for assessment of renal osteodystrophy in clinical practice?Kidney Int 102: 670, 2022PubMed)| false
SoeiroEMD, CastroL, MenezesR, EliasRM, Dos ReisLM, JorgettiV, et al.: Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: Effect of age, gender, and race. Pediatr Nephrol35: 1297–1305, 2020PubMed
SoeiroEMD, CastroL, MenezesR, EliasRM, Dos ReisLM, JorgettiV, et al.: Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: Effect of age, gender, and race. Pediatr Nephrol 35: 1297–1305, 2020PubMed)| false
KeronenS, MartolaL, FinneP, BurtonIS, KrögerH, HonkanenE: Changes in bone histomorphometry after kidney transplantation. Clin J Am Soc Nephrol14: 894–903, 2019PubMed
KeronenS, MartolaL, FinneP, BurtonIS, KrögerH, HonkanenE: Changes in bone histomorphometry after kidney transplantation. Clin J Am Soc Nephrol 14: 894–903, 2019PubMed)| false
MarquesIDB, AraújoMJCLN, GraciolliFG, Dos ReisLM, PereiraRMR, AlvarengaJC, et al.: A randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation. J Am Soc Nephrol30: 355–365, 2019PubMed
MarquesIDB, AraújoMJCLN, GraciolliFG, Dos ReisLM, PereiraRMR, AlvarengaJC, et al.: A randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation. J Am Soc Nephrol 30: 355–365, 2019PubMed)| false
EvenepoelP, BehetsGJ, ViaeneL, D’HaesePC: Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation. Kidney Int91: 469–476, 2017PubMed
EvenepoelP, BehetsGJ, ViaeneL, D’HaesePC: Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation. Kidney Int 91: 469–476, 2017PubMed)| false
VavanikunnelJ, SewingL, TriantafyllidouM, SteighardtA, BaumannS, EggerA, et al.: Determinants of low bone turnover in type 2 diabetes—The role of PTH. Calcif Tissue Int111: 587–596, 2022PubMed
VavanikunnelJ, SewingL, TriantafyllidouM, SteighardtA, BaumannS, EggerA, et al.: Determinants of low bone turnover in type 2 diabetes—The role of PTH. Calcif Tissue Int 111: 587–596, 2022PubMed)| false
Starup-LindeJ, EriksenSA, LykkeboeS, HandbergA, VestergaardP: Biochemical markers of bone turnover in diabetes patients—A meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos Int25: 1697–1708, 2014PubMed
Starup-LindeJ, EriksenSA, LykkeboeS, HandbergA, VestergaardP: Biochemical markers of bone turnover in diabetes patients—A meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos Int 25: 1697–1708, 2014PubMed)| false
PereiraL, MagalhãesJ, MendonçaL, NetoR, SantosJ, CarvalhoCG, et al.: Evaluation of renal osteodystrophy and serum bone-related biomarkers in a peritoneal dialysis population. J Bone Miner Res37: 1689–1699, 2022PubMed
PereiraL, MagalhãesJ, MendonçaL, NetoR, SantosJ, CarvalhoCG, et al.: Evaluation of renal osteodystrophy and serum bone-related biomarkers in a peritoneal dialysis population. J Bone Miner Res 37: 1689–1699, 2022PubMed)| false
KeronenSM, MartolaLAL, FinneP, BurtonIS, TongXF, KrögerHP, et al.: Clinical prediction of high-turnover bone disease after kidney transplantation. Calcif Tissue Int110: 324–333, 2022PubMed
KeronenSM, MartolaLAL, FinneP, BurtonIS, TongXF, KrögerHP, et al.: Clinical prediction of high-turnover bone disease after kidney transplantation. Calcif Tissue Int 110: 324–333, 2022PubMed)| false
JørgensenH, BehetsG, BammensB, ClaesK, MeijersB, NaesensM, et al.: Natural history of bone disease following kidney transplantation. J Am Soc Nephrol33: 638–652, 2022.
JørgensenH, BehetsG, BammensB, ClaesK, MeijersB, NaesensM, et al.: Natural history of bone disease following kidney transplantation. J Am Soc Nephrol 33: 638–652, 2022.)| false
Kidney Disease: Improving Global Outcomes CKDMBDUWG. KDIGO 2017 Clinical Practice Guideline Update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7: 1–59, 2017PubMed
42.
SalamS, GallagherO, GossielF, PaggiosiM, KhwajaA, EastellR: Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy. J Am Soc Nephrol29: 1557–1565, 2018PubMed
SalamS, GallagherO, GossielF, PaggiosiM, KhwajaA, EastellR: Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy. J Am Soc Nephrol 29: 1557–1565, 2018PubMed)| false
SpragueSM, Bellorin-FontE, JorgettiV, CarvalhoAB, MallucheHH, FerreiraA, et al.: Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis67: 559–566, 2016PubMed
SpragueSM, Bellorin-FontE, JorgettiV, CarvalhoAB, MallucheHH, FerreiraA, et al.: Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis 67: 559–566, 2016PubMed)| false
NickolasTL, ChenN, McMahonDJ, DempsterD, ZhouH, DominguezJ2nd, et al.: A microRNA approach to discriminate cortical low bone turnover in renal osteodystrophy. JBMR Plus4: e10353, 2020PubMed
NickolasTL, ChenN, McMahonDJ, DempsterD, ZhouH, DominguezJ2nd, et al.: A microRNA approach to discriminate cortical low bone turnover in renal osteodystrophy. JBMR Plus 4: e10353, 2020PubMed)| false
PichoneA, GomesCP, LimaLFC, MoreiraCA, Paranhos-NetoFP, MadeiraM, et al.: Assessment of trabecular and cortical parameters using high-resolution peripheral quantitative computed tomography, histomorphometry and microCT of iliac crest bone core in hemodialysis patients. Bone Rep16: 101173, 2022PubMed
PichoneA, GomesCP, LimaLFC, MoreiraCA, Paranhos-NetoFP, MadeiraM, et al.: Assessment of trabecular and cortical parameters using high-resolution peripheral quantitative computed tomography, histomorphometry and microCT of iliac crest bone core in hemodialysis patients. Bone Rep 16: 101173, 2022PubMed)| false
AaltonenL, KoivuviitaN, SeppänenM, TongX, KrögerH, LöyttyniemiE, et al.: Correlation between 18F-sodium fluoride positron emission tomography and bone histomorphometry in dialysis patients. Bone134: 115267, 2020PubMed
AaltonenL, KoivuviitaN, SeppänenM, TongX, KrögerH, LöyttyniemiE, et al.: Correlation between 18F-sodium fluoride positron emission tomography and bone histomorphometry in dialysis patients. Bone 134: 115267, 2020PubMed)| false
BlakeGM, PuriT, SiddiqueM, FrostML, MooreAEB, FogelmanI: Site specific measurements of bone formation using [18F] sodium fluoride PET/CT. Quant Imaging Med Surg8: 47–59, 2018PubMed
BlakeGM, PuriT, SiddiqueM, FrostML, MooreAEB, FogelmanI: Site specific measurements of bone formation using [18F] sodium fluoride PET/CT. Quant Imaging Med Surg 8: 47–59, 2018PubMed)| false
OttSM, MallucheHH, JorgettiV, ElderGJ: Importance of bone turnover for therapeutic decisions in patients with CKD-MBD. Kidney Int100: 502–505, 2021PubMed
OttSM, MallucheHH, JorgettiV, ElderGJ: Importance of bone turnover for therapeutic decisions in patients with CKD-MBD. Kidney Int 100: 502–505, 2021PubMed)| false
AdragaoT, FerreiraA, FrazaoJM, PapoilaAL, PintoI, Monier-FaugereMC, et al.: Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients. PLoS One12: e0179868, 2017PubMed
AdragaoT, FerreiraA, FrazaoJM, PapoilaAL, PintoI, Monier-FaugereMC, et al.: Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients. PLoS One 12: e0179868, 2017PubMed)| false
MarquesID, AraújoMJ, GraciolliFG, ReisLM, PereiraRM, CustódioMR, et al.: Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities. Osteoporos Int28: 1675–1683, 2017PubMed
MarquesID, AraújoMJ, GraciolliFG, ReisLM, PereiraRM, CustódioMR, et al.: Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities. Osteoporos Int 28: 1675–1683, 2017PubMed)| false
FerreiraAC, MendesM, SilvaC, CotovioP, AiresI, NavarroD, et al.: Bone densitometry versus bone histomorphometry in renal transplanted patients: A cross-sectional study. Transpl Int34: 1065–1073, 2021PubMed
FerreiraAC, MendesM, SilvaC, CotovioP, AiresI, NavarroD, et al.: Bone densitometry versus bone histomorphometry in renal transplanted patients: A cross-sectional study. Transpl Int 34: 1065–1073, 2021PubMed)| false
PimentelA, BoverJ, ElderG, Cohen-SolalM, Ureña-TorresPA: The use of imaging techniques in chronic kidney disease-mineral and bone disorders (CKD-MBD)—A systematic review. Diagnostics (Basel)11: 772, 2021PubMed
PimentelA, BoverJ, ElderG, Cohen-SolalM, Ureña-TorresPA: The use of imaging techniques in chronic kidney disease-mineral and bone disorders (CKD-MBD)—A systematic review. Diagnostics (Basel) 11: 772, 2021PubMed)| false
EvenepoelP, CunninghamJ, FerrariS, HaarhausM, JavaidMK, Lafage-ProustMH, et al.; European Renal Osteodystrophy (EUROD) workgroup; an initiative of the CKD-MBD working group of the ERA-EDTA; and the committee of Scientific Advisors and National Societies of the IOF: Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: A call for a shift from nihilism to pragmatism. Osteoporos Int32: 2397–2405, 2021PubMed
EvenepoelP, CunninghamJ, FerrariS, HaarhausM, JavaidMK, Lafage-ProustMH, et al.; European Renal Osteodystrophy (EUROD) workgroup; an initiative of the CKD-MBD working group of the ERA-EDTA; and the committee of Scientific Advisors and National Societies of the IOF: Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: A call for a shift from nihilism to pragmatism. Osteoporos Int 32: 2397–2405, 2021PubMed)| false
LeBoffMS, ChouSH, RatliffKA, CookNR, KhuranaB, KimE, et al.: Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med387: 299–309, 2022PubMed
LeBoffMS, ChouSH, RatliffKA, CookNR, KhuranaB, KimE, et al.: Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med 387: 299–309, 2022PubMed)| false
